FBRX
insider transactionsForte Biosciences, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Paul A. Wagner KEY
CEO, Secretary and Chair of t…
$0
500.0K sh
Own New
-
Grant·A
Antony A Riley KEY
CHIEF FINANCIAL OFFICER
$0
22.0K sh
Own New
-
Grant·A
Director
$0
22.0K sh
Own New
-
Grant·A
Director
$0
18.4K sh
Own New
-
Grant·A
Director
$0
18.4K sh
Own New
-
Grant·A
Director
$0
18.4K sh
Own New
-
Grant·A
Director
$0
18.4K sh
Own New
-
Grant·A
Director
$0
18.4K sh
Own New
-
Grant·A
Director
$0
18.4K sh
Own New
-
Exercise·M
Paul A. Wagner KEY
CEO, Secretary and Chair of t…
$0
1.2K sh
Own +50%
-
Other·F
Paul A. Wagner KEY
CEO, Secretary and Chair of t…
$2.4K
98 sh · $24.86
Own -0%
-
Exercise·M
Paul A. Wagner KEY
CEO, Secretary and Chair of t…
—
1.2K sh
Own +2%
-
Exercise·M
Antony A Riley KEY
CHIEF FINANCIAL OFFICER
$0
375 sh
Own +50%
-
Other·F
Antony A Riley KEY
CHIEF FINANCIAL OFFICER
$3.3K
134 sh · $24.86
Own -0%
-
Exercise·M
Antony A Riley KEY
CHIEF FINANCIAL OFFICER
—
375 sh
Own +1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Paul A. Wagner KEY | Grant A | 500.0K | $0 |
| Jun 16, 2026 | Antony A Riley KEY | Grant A | 22.0K | $0 |
| Jun 9, 2026 | Scott C. Brun | Grant A | 22.0K | $0 |
| May 29, 2026 | Shivpreet Singh Kapoor | Grant A | 18.4K | $0 |
| May 29, 2026 | Steven Kornfeld | Grant A | 18.4K | $0 |
| May 29, 2026 | Richard G Vincent | Grant A | 18.4K | $0 |
| May 29, 2026 | David W Gryska | Grant A | 18.4K | $0 |
| May 29, 2026 | Stephen K Doberstein | Grant A | 18.4K | $0 |
| May 29, 2026 | Scott C. Brun | Grant A | 18.4K | $0 |
| Apr 1, 2026 | Paul A. Wagner KEY | Exercise M | 1.2K | $0 |
| Apr 1, 2026 | Paul A. Wagner KEY | Other F | 98 | $2.4K |
| Apr 1, 2026 | Paul A. Wagner KEY | Exercise M | 1.2K | — |
| Apr 1, 2026 | Antony A Riley KEY | Exercise M | 375 | $0 |
| Apr 1, 2026 | Antony A Riley KEY | Other F | 134 | $3.3K |
| Apr 1, 2026 | Antony A Riley KEY | Exercise M | 375 | — |
About FBRX insider trading
This page tracks insider transactions for Forte Biosciences, Inc. (FBRX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.